Jerry M. Collins

Accelerated Titration Designs for Phase I Clinical Trials in Oncology

Richard Simon, Larry Rubinstein, Susan G. Arbuck et al. · JNCI Journal of the National Cancer Institute · 1997 · 640 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacologic rationale for regional drug delivery.

Jerry M. Collins · Journal of Clinical Oncology · 1984 · 467 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

Susan L. Holbeck, Richard F. Camalier, James A. Crowell et al. · Cancer Research · 2017 · 392 citations · Full text

Medicine, Oncology, Pharmacology +12

Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

Raymond W. Klecker, Jerry M. Collins, Robert Yarchoan et al. · Clinical Pharmacology & Therapeutics · 1987 · 381 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +11

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 329 citations · Full text

Medicine, Oncology, Pharmacology +16